Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey

World Medical Association Declaration of Helsinki

JAMA · 2013 · 29.4K citations

Health Professions, Health Sciences, Clinical Medicine +2

Emergency Hospitalizations for Adverse Drug Events in Older Americans

Daniel S. Budnitz, Maribeth C. Lovegrove, Nadine Shehab et al. · New England Journal of Medicine · 2011 · 1.8K citations · Full text

Pharmacy, Emergency Medicine, Geriatric Medicine +13

Effect of <i>VKORC1</i> Haplotypes on Transcriptional Regulation and Warfarin Dose

Mark J. Rieder, Alex P. Reiner, Brian F. Gage et al. · New England Journal of Medicine · 2005 · 1.4K citations · Full text

Life Sciences, Genetics, Pharmacology +14

Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

Mitchell K. Higashi · JAMA · 2002 · 1.1K citations

Medicine, Genetics, Pharmacology +17

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

Lars Wallentin, Salim Yusuf, Michael D. Ezekowitz et al. · The Lancet · 2010 · 1K citations

Medicine, Cardiology, Pharmacology +15